Clinical Trial Update: Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atomoxetine for Attention Deficit Hyperactivity Disorder in Korean children and adolescents. The study is completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-12-14